EGFR and neoplasm: The primary mechanism of action of cetuximab is the blockade of ligand-induced EGFR activation and downstream signaling, including signaling through the PI3K/Akt and MAPK/Erk pathways which have been linked to many processes crucial to tumor progression, including metastasis and cell survival, proliferation, adhesion, differentiation, migration, transformation, and motility36.